US7574682024 - ADR
2.2 -0.12 (-5.17%)
RedHill has elected to terminate RHB-204's U.S. Phase 3 study for Non-tuberculosis Mycobacteria (NTM) disease due to low accrual rate and plans to shift...
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has received...
/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the granting of two...
Having extinguished all debt and significantly reduced cost-base, RedHill is now focused on late-stage pipeline advancement, in collaboration with U.S. and...
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it received...
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed...
/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...
RedHill Biopharma (RDHL) plans to change the ADS ratio to its non-traded ordinary shares, from one ADS representing ten ordinary shares to one ADS representing four...
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it plans to...
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced agreement, with a...
/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the extinguishment...
GeneDx (WGS) stock is taking a beating on Friday after the company revealed a $150 million proposed public stock offering.
ContraFect (CFRX) stock is falling on Friday after the company provided an update on its potential delisting from the Nasdaq Capital Market.
Akanda (AKAN) stock is on the rise Friday as the company's shares continue a rally that started yesterday following an FDA update.
Redhill Biopharma (RDHL) stock is rocketing higher on Friday after getting positive patent news from the USPTO for RHB-204.
It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
RedHill Biopharma (RDHL) said results from its phase two study of RHB-107 for COVID-19 was published in the peer-reviewed International Journal of Infectious Diseases. Read more here.
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of an...
RedHill Biopharma (RDHL) is trading 1.6% higher after the company said the U.S